- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT06126276
Test af brugen af Neratinib eller kombinationen af Neratinib og Palbociclib målrettet behandling for HER2+ solide tumorer (et ComboMATCH-behandlingsforsøg)
Et randomiseret forsøg med Neratinib, en Pan-ERBB-hæmmer, alene eller i kombination med Palbociclib, en CDK4/6-hæmmer, hos patienter med HER2+ gynækologiske kræftformer og andre solide tumorer: Et ComboMATCH-behandlingsforsøg
This phase II ComboMATCH treatment trial compares the effect of neratinib to the combination of neratinib and palbociclib in treating patients with HER2 positive solid tumors. Neratinib and palbociclib are in a class of medications called kinase inhibitors. They work by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of tumor cells. Giving neratinib and palbociclib in combination may shrink or stabilize cancers that over-express a specific biomarker called HER2.
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
PRIMARY OBJECTIVE:
I. To investigate the efficacy of neratinib plus palbociclib (PD-0332991) compared to neratinib maleate (neratinib) alone in patients with HER2+ gynecologic cancers and HER2+ solid tumors by evaluating progression-free survival (PFS).
SECONDARY OBJECTIVES:
I. To investigate outcome in terms of objective response rate (ORR) by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1.
II. To investigate clinical benefit rate (ORR + stable disease at 16 weeks). III. To evaluate overall (OS) survival. IV. To evaluate the ORR of patients who crossed over from neratinib monotherapy to neratinib-palbociclib combination.
V. To investigate adverse events especially grade 3 and 4 toxicities by Common Terminology Criteria for Adverse Events (CTCAE) version (v) 5.0.
VI. Collect tissue and provide it to the ComboMATCH Registration Protocol to assess concordance between the diagnostic tumor mutation profile generated by the Designated Laboratories, the pre-treatment biopsy mutation profile, and the pre-treatment circulating tumor-derived deoxyribonucleic acid (ctDNA) mutation profile from plasma, as described in ComboMATCH Registration Protocol.
EXPLORATORY TRANSLATIONAL OBJECTIVES:
I. To investigate the role of ctDNA-HER2 status at baseline and during follow up to assess if it predicts response to therapy and disease progression and if it does correlate with tumor tissue based HER2 status.
II. To investigate if activation of the pathways of interest (PI3K/mTOR and RB1, CCND1-CDK4/6 CDK and RAS/RAF/MAPK) in tumor tissue as well as blood/ctDNA correlate with response or resistance to therapy.
III. To correlate extent of HER2 amplification with response to treatment and with HER2 expression by immunohistochemistry or fluorescence in situ hybridization (FISH).
IV. To correlate the extent of HER2 amplification with HER2 expression by RNA and protein immunohistochemistry (IHC) analyses and FISH.
V. To correlate expression of Rb1, CCND1, CCNE1, CDK4/6 protein expression with response to treatment.
VI. Assess alteration in RB1-CDK pathway in neratinib resistant patients at time of progression on monotherapy compared to combination neratinib-palbociclib.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I: Patients receive neratinib maleate orally (PO) once daily (QD) on days 1-14 of cycle 0 in the absence of disease progression or unacceptable toxicity. Patients then receive neratinib maleate PO QD on days 1-28 of each subsequent cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients who experience progression may crossover to Arm II. Patients undergo echocardiogram (ECHO) or multi-gated acquisition scan (MUGA) during screening and on study, and computed tomography (CT) or magnetic resonance imaging (MRI) and collection of blood samples throughout the trial. Patients may also undergo tumor biopsy during screening and on study.
ARM II: Patients receive neratinib maleate PO QD on days 1-14 of cycle 0 in the absence of disease progression or unacceptable toxicity. Patients then receive neratinib maleate PO QD on days 1-28 and palbociclib PO QD on days 1-21 of each subsequent cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients undergo ECHO or MUGA during screening and on study, and CT or MRI and collection of blood samples throughout the trial. Patients may also undergo tumor biopsy during screening and on study.
After completion of study treatment, patients are followed up every 3 months for 2 years.
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Fase 2
Kontakter og lokationer
Studiesteder
-
-
Alabama
-
Birmingham, Alabama, Forenede Stater, 35233
- Rekruttering
- University of Alabama at Birmingham Cancer Center
-
Ledende efterforsker:
- Rebecca C. Arend
-
Kontakt:
- Site Public Contact
- E-mail: gingerreeves@uabmc.edu
-
Mobile, Alabama, Forenede Stater, 36688
- Rekruttering
- University of South Alabama Mitchell Cancer Institute
-
Kontakt:
- Site Public Contact
- Telefonnummer: 251-445-9870
- E-mail: pfrancisco@usouthal.edu
-
Ledende efterforsker:
- Ahmed Abdalla
-
-
Alaska
-
Anchorage, Alaska, Forenede Stater, 99508
- Rekruttering
- Alaska Women's Cancer Care
-
Ledende efterforsker:
- Dan S. Zuckerman
-
Kontakt:
- Site Public Contact
- Telefonnummer: 907-212-6871
- E-mail: AKPAMC.OncologyResearchSupport@providence.org
-
-
California
-
Encinitas, California, Forenede Stater, 92024
- Rekruttering
- UC San Diego Health System - Encinitas
-
Kontakt:
- Site Public Contact
- Telefonnummer: 760-536-7700
-
Ledende efterforsker:
- Peter Vu
-
La Jolla, California, Forenede Stater, 92093
- Rekruttering
- UC San Diego Moores Cancer Center
-
Kontakt:
- Site Public Contact
- Telefonnummer: 858-822-5354
- E-mail: cancercto@ucsd.edu
-
Ledende efterforsker:
- Peter Vu
-
Los Angeles, California, Forenede Stater, 90048
- Rekruttering
- Cedars-Sinai Medical Center
-
Ledende efterforsker:
- Omid Hamid
-
Kontakt:
- Site Public Contact
- Telefonnummer: 310-423-2133
- E-mail: Cancer.trial.info@cshs.org
-
Los Angeles, California, Forenede Stater, 90025
- Rekruttering
- The Angeles Clinic and Research Institute - West Los Angeles Office
-
Kontakt:
- Site Public Contact
- Telefonnummer: 888-823-5923
- E-mail: ctsucontact@westat.com
-
Ledende efterforsker:
- Omid Hamid
-
San Diego, California, Forenede Stater, 92103
- Rekruttering
- UC San Diego Medical Center - Hillcrest
-
Kontakt:
- Site Public Contact
- E-mail: rhabbaba@health.ucsd.edu
-
Ledende efterforsker:
- Peter Vu
-
-
Florida
-
Aventura, Florida, Forenede Stater, 33180
- Rekruttering
- UM Sylvester Comprehensive Cancer Center at Aventura
-
Ledende efterforsker:
- Matthew P. Schlumbrecht
-
Kontakt:
- Site Public Contact
- Telefonnummer: 954-461-2180
-
Coral Gables, Florida, Forenede Stater, 33146
- Rekruttering
- UM Sylvester Comprehensive Cancer Center at Coral Gables
-
Ledende efterforsker:
- Matthew P. Schlumbrecht
-
Kontakt:
- Site Public Contact
- Telefonnummer: 305-243-2647
-
Coral Springs, Florida, Forenede Stater, 33065
- Rekruttering
- UM Sylvester Comprehensive Cancer Center at Coral Springs
-
Ledende efterforsker:
- Matthew P. Schlumbrecht
-
Kontakt:
- Site Public Contact
- Telefonnummer: 305-243-2647
-
Deerfield Beach, Florida, Forenede Stater, 33442
- Rekruttering
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach
-
Ledende efterforsker:
- Matthew P. Schlumbrecht
-
Kontakt:
- Site Public Contact
- Telefonnummer: 305-243-2647
-
Doral, Florida, Forenede Stater, 33166
- Rekruttering
- UM Sylvester Comprehensive Cancer Center at Doral
-
Ledende efterforsker:
- Matthew P. Schlumbrecht
-
Kontakt:
- Site Public Contact
- E-mail: kginnity@med.miami.edu
-
Hollywood, Florida, Forenede Stater, 33021
- Rekruttering
- UM Sylvester Comprehensive Cancer Center at Hollywood
-
Ledende efterforsker:
- Matthew P. Schlumbrecht
-
Kontakt:
- Site Public Contact
- Telefonnummer: 305-243-2647
-
Miami, Florida, Forenede Stater, 33136
- Rekruttering
- University of Miami Miller School of Medicine-Sylvester Cancer Center
-
Ledende efterforsker:
- Matthew P. Schlumbrecht
-
Kontakt:
- Site Public Contact
- Telefonnummer: 305-243-2647
-
Miami, Florida, Forenede Stater, 33176
- Rekruttering
- UM Sylvester Comprehensive Cancer Center at Kendall
-
Ledende efterforsker:
- Matthew P. Schlumbrecht
-
Kontakt:
- Site Public Contact
- Telefonnummer: 305-243-2647
-
North Miami, Florida, Forenede Stater, 33181
- Rekruttering
- University of Miami Sylvester Comprehensive Cancer Center at Sole Mia
-
Ledende efterforsker:
- Matthew P. Schlumbrecht
-
Kontakt:
- Site Public Contact
- E-mail: kginnity@med.miami.edu
-
Plantation, Florida, Forenede Stater, 33324
- Rekruttering
- UM Sylvester Comprehensive Cancer Center at Plantation
-
Ledende efterforsker:
- Matthew P. Schlumbrecht
-
Kontakt:
- Site Public Contact
- Telefonnummer: 305-243-2647
-
-
Idaho
-
Boise, Idaho, Forenede Stater, 83712
- Rekruttering
- Saint Luke's Cancer Institute - Boise
-
Ledende efterforsker:
- Dan S. Zuckerman
-
Kontakt:
- Site Public Contact
- Telefonnummer: 208-381-2774
- E-mail: eslinget@slhs.org
-
Boise, Idaho, Forenede Stater, 83706
- Rekruttering
- Saint Alphonsus Cancer Care Center-Boise
-
Kontakt:
- Site Public Contact
- Telefonnummer: 734-712-3671
- E-mail: stephanie.couch@stjoeshealth.org
-
Ledende efterforsker:
- Tareq Al baghdadi
-
Caldwell, Idaho, Forenede Stater, 83605
- Rekruttering
- Saint Alphonsus Cancer Care Center-Caldwell
-
Kontakt:
- Site Public Contact
- Telefonnummer: 734-712-3671
- E-mail: stephanie.couch@stjoeshealth.org
-
Ledende efterforsker:
- Tareq Al baghdadi
-
Coeur d'Alene, Idaho, Forenede Stater, 83814
- Rekruttering
- Kootenai Health - Coeur d'Alene
-
Ledende efterforsker:
- John M. Schallenkamp
-
Kontakt:
- Site Public Contact
- Telefonnummer: 406-969-6060
- E-mail: mccinfo@mtcancer.org
-
Fruitland, Idaho, Forenede Stater, 83619
- Rekruttering
- Saint Luke's Cancer Institute - Fruitland
-
Ledende efterforsker:
- Dan S. Zuckerman
-
Kontakt:
- Site Public Contact
- Telefonnummer: 208-381-2774
- E-mail: eslinget@slhs.org
-
Meridian, Idaho, Forenede Stater, 83642
- Rekruttering
- Saint Luke's Cancer Institute - Meridian
-
Ledende efterforsker:
- Dan S. Zuckerman
-
Kontakt:
- Site Public Contact
- Telefonnummer: 208-381-2774
- E-mail: eslinget@slhs.org
-
Nampa, Idaho, Forenede Stater, 83687
- Rekruttering
- Saint Luke's Cancer Institute - Nampa
-
Ledende efterforsker:
- Dan S. Zuckerman
-
Kontakt:
- Site Public Contact
- Telefonnummer: 208-381-2774
- E-mail: eslinget@slhs.org
-
Nampa, Idaho, Forenede Stater, 83687
- Rekruttering
- Saint Alphonsus Cancer Care Center-Nampa
-
Kontakt:
- Site Public Contact
- Telefonnummer: 406-969-6060
- E-mail: mccinfo@mtcancer.org
-
Ledende efterforsker:
- Tareq Al baghdadi
-
Post Falls, Idaho, Forenede Stater, 83854
- Rekruttering
- Kootenai Clinic Cancer Services - Post Falls
-
Ledende efterforsker:
- John M. Schallenkamp
-
Kontakt:
- Site Public Contact
- Telefonnummer: 406-969-6060
- E-mail: mccinfo@mtcancer.org
-
Sandpoint, Idaho, Forenede Stater, 83864
- Rekruttering
- Kootenai Clinic Cancer Services - Sandpoint
-
Ledende efterforsker:
- John M. Schallenkamp
-
Kontakt:
- Site Public Contact
- Telefonnummer: 406-969-6060
- E-mail: mccinfo@mtcancer.org
-
-
Illinois
-
Carterville, Illinois, Forenede Stater, 62918
- Rekruttering
- SIH Cancer Institute
-
Ledende efterforsker:
- Bryan A. Faller
-
Kontakt:
- Site Public Contact
- Telefonnummer: 618-985-3333
- E-mail: clinical.research@sih.net
-
Chicago, Illinois, Forenede Stater, 60612
- Aktiv, ikke rekrutterende
- University of Illinois
-
Chicago, Illinois, Forenede Stater, 60612
- Suspenderet
- John H Stroger Jr Hospital of Cook County
-
Danville, Illinois, Forenede Stater, 61832
- Rekruttering
- Carle at The Riverfront
-
Ledende efterforsker:
- Maria T. Grosse-Perdekamp
-
Kontakt:
- Site Public Contact
- Telefonnummer: 800-446-5532
- E-mail: Research@Carle.com
-
Decatur, Illinois, Forenede Stater, 62526
- Rekruttering
- Cancer Care Specialists of Illinois - Decatur
-
Ledende efterforsker:
- Bryan A. Faller
-
Kontakt:
- Site Public Contact
- Telefonnummer: 217-876-4762
- E-mail: morganthaler.jodi@mhsil.com
-
Decatur, Illinois, Forenede Stater, 62526
- Rekruttering
- Decatur Memorial Hospital
-
Ledende efterforsker:
- Bryan A. Faller
-
Kontakt:
- Site Public Contact
- Telefonnummer: 217-876-4762
- E-mail: morganthaler.jodi@mhsil.com
-
Effingham, Illinois, Forenede Stater, 62401
- Rekruttering
- Carle Physician Group-Effingham
-
Kontakt:
- Site Public Contact
- Telefonnummer: 800-446-5532
- E-mail: Research@carle.com
-
Ledende efterforsker:
- Maria T. Grosse-Perdekamp
-
Effingham, Illinois, Forenede Stater, 62401
- Rekruttering
- Crossroads Cancer Center
-
Ledende efterforsker:
- Bryan A. Faller
-
Kontakt:
- Site Public Contact
- Telefonnummer: 217-876-4762
- E-mail: morganthaler.jodi@mhsil.com
-
Evanston, Illinois, Forenede Stater, 60201
- Rekruttering
- NorthShore University HealthSystem-Evanston Hospital
-
Kontakt:
- Site Public Contact
- Telefonnummer: 847-570-2109
-
Ledende efterforsker:
- Mary T. Jenkins Vogel
-
Glenview, Illinois, Forenede Stater, 60026
- Rekruttering
- NorthShore University HealthSystem-Glenbrook Hospital
-
Kontakt:
- Site Public Contact
- Telefonnummer: 847-570-2109
-
Ledende efterforsker:
- Mary T. Jenkins Vogel
-
Highland Park, Illinois, Forenede Stater, 60035
- Rekruttering
- NorthShore University HealthSystem-Highland Park Hospital
-
Kontakt:
- Site Public Contact
- Telefonnummer: 847-570-2109
-
Ledende efterforsker:
- Mary T. Jenkins Vogel
-
Mattoon, Illinois, Forenede Stater, 61938
- Rekruttering
- Carle Physician Group-Mattoon/Charleston
-
Kontakt:
- Site Public Contact
- Telefonnummer: 800-446-5532
- E-mail: Research@carle.com
-
Ledende efterforsker:
- Maria T. Grosse-Perdekamp
-
Normal, Illinois, Forenede Stater, 61761
- Rekruttering
- Carle BroMenn Medical Center
-
Ledende efterforsker:
- Maria T. Grosse-Perdekamp
-
Kontakt:
- Site Public Contact
- Telefonnummer: 800-446-5532
- E-mail: Research@Carle.com
-
Normal, Illinois, Forenede Stater, 61761
- Rekruttering
- Carle Cancer Institute Normal
-
Ledende efterforsker:
- Maria T. Grosse-Perdekamp
-
Kontakt:
- Site Public Contact
- Telefonnummer: 800-446-5532
- E-mail: Research@Carle.com
-
O'Fallon, Illinois, Forenede Stater, 62269
- Rekruttering
- Cancer Care Center of O'Fallon
-
Ledende efterforsker:
- Bryan A. Faller
-
Kontakt:
- Site Public Contact
- Telefonnummer: 217-876-4762
- E-mail: morganthaler.jodi@mhsil.com
-
Rockford, Illinois, Forenede Stater, 61114
- Rekruttering
- Mercyhealth Cancer Institute - Rockford
-
Ledende efterforsker:
- Mayur Narkhede
-
Kontakt:
- Site Public Contact
- Telefonnummer: 815-971-5858
- E-mail: oncologyclinicaltrials@mhemail.org
-
Springfield, Illinois, Forenede Stater, 62702
- Rekruttering
- Southern Illinois University School of Medicine
-
Ledende efterforsker:
- Bryan A. Faller
-
Kontakt:
- Site Public Contact
- Telefonnummer: 217-545-7929
-
Springfield, Illinois, Forenede Stater, 62702
- Rekruttering
- Springfield Clinic
-
Ledende efterforsker:
- Bryan A. Faller
-
Kontakt:
- Site Public Contact
- Telefonnummer: 800-444-7541
-
Springfield, Illinois, Forenede Stater, 62781
- Rekruttering
- Springfield Memorial Hospital
-
Ledende efterforsker:
- Bryan A. Faller
-
Kontakt:
- Site Public Contact
- Telefonnummer: 217-528-7541
- E-mail: pallante.beth@mhsil.com
-
Urbana, Illinois, Forenede Stater, 61801
- Rekruttering
- Carle Cancer Center
-
Kontakt:
- Site Public Contact
- Telefonnummer: 800-446-5532
- E-mail: Research@carle.com
-
Ledende efterforsker:
- Maria T. Grosse-Perdekamp
-
-
Indiana
-
Michigan City, Indiana, Forenede Stater, 46360
- Rekruttering
- Woodland Cancer Care Center
-
Kontakt:
- Site Public Contact
- Telefonnummer: 219-861-5800
- E-mail: Anna.Huron@franciscanalliance.org
-
Ledende efterforsker:
- William H. Bae
-
-
Iowa
-
Ankeny, Iowa, Forenede Stater, 50023
- Rekruttering
- UI Health Care Mission Cancer and Blood - Ankeny Clinic
-
Kontakt:
- Site Public Contact
- Telefonnummer: 515-241-3305
-
Ledende efterforsker:
- Seema Harichand-Herdt
-
Des Moines, Iowa, Forenede Stater, 50309
- Rekruttering
- UI Health Care Mission Cancer and Blood - Des Moines Clinic
-
Kontakt:
- Site Public Contact
- Telefonnummer: 515-241-3305
-
Ledende efterforsker:
- Seema Harichand-Herdt
-
Des Moines, Iowa, Forenede Stater, 50314
- Rekruttering
- UI Health Care Mission Cancer and Blood - Laurel Clinic
-
Kontakt:
- Site Public Contact
- Telefonnummer: 515-241-3305
-
Ledende efterforsker:
- Seema Harichand-Herdt
-
Waukee, Iowa, Forenede Stater, 50263
- Rekruttering
- UI Health Care Mission Cancer and Blood - Waukee Clinic
-
Kontakt:
- Site Public Contact
- Telefonnummer: 515-241-3305
-
Ledende efterforsker:
- Seema Harichand-Herdt
-
-
Kentucky
-
Lexington, Kentucky, Forenede Stater, 40536
- Rekruttering
- University of Kentucky/Markey Cancer Center
-
Kontakt:
- Site Public Contact
- Telefonnummer: 859-257-3379
-
Ledende efterforsker:
- Susanne M. Arnold
-
Lexington, Kentucky, Forenede Stater, 40509
- Rekruttering
- CommonSpirit Saint Joseph Medical Center - East Lexington
-
Ledende efterforsker:
- Loretta J. Nastoupil
-
Kontakt:
- Site Public Contact
- Telefonnummer: 720-874-1881
- E-mail: ResearchInstituteInquiries@CommonSpirit.org
-
-
Maine
-
Augusta, Maine, Forenede Stater, 04330
- Rekruttering
- Harold Alfond Center for Cancer Care
-
Kontakt:
- Site Public Contact
- Telefonnummer: 207-626-4855
-
Ledende efterforsker:
- Leslie S. Bradford
-
Brewer, Maine, Forenede Stater, 04412
- Rekruttering
- Lafayette Family Cancer Center-EMMC
-
Ledende efterforsker:
- Sarah J. Sinclair
-
Kontakt:
- Site Public Contact
- Telefonnummer: 800-987-3005
-
Scarborough, Maine, Forenede Stater, 04074
- Rekruttering
- MaineHealth Maine Medical Center- Scarborough
-
Ledende efterforsker:
- Leslie S. Bradford
-
Kontakt:
- Site Public Contact
- Telefonnummer: 207-396-8670
- E-mail: clinicalresearch@mainehealth.org
-
-
Maryland
-
Baltimore, Maryland, Forenede Stater, 21201
- Rekruttering
- University of Maryland/Greenebaum Cancer Center
-
Kontakt:
- Site Public Contact
- Telefonnummer: 800-888-8823
-
Ledende efterforsker:
- Ranee Mehra
-
Bethesda, Maryland, Forenede Stater, 20892
- Rekruttering
- National Institutes of Health Clinical Center
-
Kontakt:
- Site Public Contact
- Telefonnummer: 800-411-1222
-
Ledende efterforsker:
- Sarah Shin
-
Bethesda, Maryland, Forenede Stater, 20889-5600
- Rekruttering
- Walter Reed National Military Medical Center
-
Kontakt:
- Site Public Contact
- Telefonnummer: 301-319-2100
-
Ledende efterforsker:
- Christopher Tarney
-
Cumberland, Maryland, Forenede Stater, 21502
- Rekruttering
- UPMC Western Maryland
-
Kontakt:
- Site Public Contact
- Telefonnummer: 240-964-1400
-
Ledende efterforsker:
- Sarah E. Taylor
-
-
Michigan
-
Ann Arbor, Michigan, Forenede Stater, 48106
- Rekruttering
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
-
Kontakt:
- Site Public Contact
- Telefonnummer: 734-712-7251
- E-mail: MCRCwebsitecontactform@stjoeshealth.org
-
Ledende efterforsker:
- Tareq Al baghdadi
-
Brighton, Michigan, Forenede Stater, 48114
- Rekruttering
- Trinity Health IHA Medical Group Hematology Oncology - Brighton
-
Kontakt:
- Site Public Contact
- Telefonnummer: 734-712-7251
- E-mail: MCRCwebsitecontactform@stjoeshealth.org
-
Ledende efterforsker:
- Tareq Al baghdadi
-
Canton, Michigan, Forenede Stater, 48188
- Rekruttering
- Trinity Health IHA Medical Group Hematology Oncology - Canton
-
Kontakt:
- Site Public Contact
- Telefonnummer: 734-712-7251
- E-mail: MCRCwebsitecontactform@stjoeshealth.org
-
Ledende efterforsker:
- Tareq Al baghdadi
-
Chelsea, Michigan, Forenede Stater, 48118
- Rekruttering
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
-
Kontakt:
- Site Public Contact
- Telefonnummer: 734-712-7251
- E-mail: MCRCwebsitecontactform@stjoeshealth.org
-
Ledende efterforsker:
- Tareq Al baghdadi
-
Dearborn, Michigan, Forenede Stater, 48124
- Suspenderet
- Corewell Health Dearborn Hospital
-
Escanaba, Michigan, Forenede Stater, 49829
- Rekruttering
- OSF Saint Francis Hospital and Medical Group
-
Ledende efterforsker:
- Matthew L. Ryan
-
Kontakt:
- Site Public Contact
- Telefonnummer: 920-433-8889
- E-mail: WI_research_admin@hshs.org
-
Farmington Hills, Michigan, Forenede Stater, 48336
- Suspenderet
- Corewell Health Farmington Hills Hospital
-
Flint, Michigan, Forenede Stater, 48503
- Rekruttering
- Genesys Hurley Cancer Institute
-
Kontakt:
- Site Public Contact
- Telefonnummer: 810-762-8038
- E-mail: wstrong@ghci.org
-
Ledende efterforsker:
- Tareq Al baghdadi
-
Flint, Michigan, Forenede Stater, 48503
- Rekruttering
- Hurley Medical Center
-
Kontakt:
- Site Public Contact
- Telefonnummer: 810-762-8038
- E-mail: wstrong@ghci.org
-
Ledende efterforsker:
- Tareq Al baghdadi
-
Flint, Michigan, Forenede Stater, 48503
- Suspenderet
- Genesee Hematology Oncology PC
-
Flint, Michigan, Forenede Stater, 48503
- Rekruttering
- Cancer Hematology Centers - Flint
-
Kontakt:
- Site Public Contact
- Telefonnummer: 810-762-8038
- E-mail: wstrong@ghci.org
-
Ledende efterforsker:
- Tareq Al baghdadi
-
Lansing, Michigan, Forenede Stater, 48912
- Rekruttering
- University of Michigan Health - Sparrow Lansing
-
Ledende efterforsker:
- Tareq Al baghdadi
-
Kontakt:
- Site Public Contact
- Telefonnummer: 517-364-3712
- E-mail: harsha.trivedi@umhsparrow.org
-
Livonia, Michigan, Forenede Stater, 48154
- Rekruttering
- Trinity Health Saint Mary Mercy Livonia Hospital
-
Kontakt:
- Site Public Contact
- Telefonnummer: 734-712-7251
- E-mail: MCRCwebsitecontactform@stjoeshealth.org
-
Ledende efterforsker:
- Tareq Al baghdadi
-
Pontiac, Michigan, Forenede Stater, 48341
- Rekruttering
- Trinity Health Saint Joseph Mercy Oakland Hospital
-
Kontakt:
- Site Public Contact
- Telefonnummer: 734-712-7251
- E-mail: MCRCwebsitecontactform@stjoeshealth.org
-
Ledende efterforsker:
- Tareq Al baghdadi
-
Royal Oak, Michigan, Forenede Stater, 48073
- Suspenderet
- Corewell Health William Beaumont University Hospital
-
Troy, Michigan, Forenede Stater, 48085
- Suspenderet
- Corewell Health Beaumont Troy Hospital
-
Ypsilanti, Michigan, Forenede Stater, 48197
- Rekruttering
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
-
Kontakt:
- Site Public Contact
- Telefonnummer: 734-712-7251
- E-mail: MCRCwebsitecontactform@stjoeshealth.org
-
Ledende efterforsker:
- Tareq Al baghdadi
-
-
Minnesota
-
Bemidji, Minnesota, Forenede Stater, 56601
- Rekruttering
- Sanford Joe Lueken Cancer Center
-
Ledende efterforsker:
- Daniel Almquist
-
Kontakt:
- Site Public Contact
- Telefonnummer: 218-333-5000
- E-mail: OncologyClinicalTrialsFargo@sanfordhealth.org
-
Deer River, Minnesota, Forenede Stater, 56636
- Rekruttering
- Essentia Health - Deer River Clinic
-
Kontakt:
- Site Public Contact
- Telefonnummer: 218-786-3308
- E-mail: CancerTrials@EssentiaHealth.org
-
Ledende efterforsker:
- Bret E. Friday
-
Duluth, Minnesota, Forenede Stater, 55805
- Rekruttering
- Essentia Health Cancer Center
-
Kontakt:
- Site Public Contact
- Telefonnummer: 218-786-3308
- E-mail: CancerTrials@EssentiaHealth.org
-
Ledende efterforsker:
- Bret E. Friday
-
Edina, Minnesota, Forenede Stater, 55435
- Rekruttering
- Minnesota Oncology - Edina
-
Ledende efterforsker:
- Joleen M. Hubbard
-
Kontakt:
- Site Public Contact
- Telefonnummer: 952-993-1517
- E-mail: mmcorc@healthpartners.com
-
Hibbing, Minnesota, Forenede Stater, 55746
- Rekruttering
- Essentia Health Hibbing Clinic
-
Ledende efterforsker:
- Bret E. Friday
-
Kontakt:
- Site Public Contact
- Telefonnummer: 218-786-3308
-
Maplewood, Minnesota, Forenede Stater, 55109
- Rekruttering
- Saint John's Hospital - Healtheast
-
Ledende efterforsker:
- Joleen M. Hubbard
-
Kontakt:
- Site Public Contact
- Telefonnummer: 952-993-1517
- E-mail: mmcorc@healthpartners.com
-
Rochester, Minnesota, Forenede Stater, 55905
- Rekruttering
- Mayo Clinic in Rochester
-
Kontakt:
- Site Public Contact
- Telefonnummer: 855-776-0015
-
Ledende efterforsker:
- Grace M. Choong
-
Sandstone, Minnesota, Forenede Stater, 55072
- Rekruttering
- Essentia Health Sandstone
-
Kontakt:
- Site Public Contact
- Telefonnummer: 218-786-3308
- E-mail: CancerTrials@EssentiaHealth.org
-
Ledende efterforsker:
- Bret E. Friday
-
Virginia, Minnesota, Forenede Stater, 55792
- Rekruttering
- Essentia Health Virginia Clinic
-
Kontakt:
- Site Public Contact
- Telefonnummer: 218-786-3308
- E-mail: CancerTrials@EssentiaHealth.org
-
Ledende efterforsker:
- Bret E. Friday
-
-
Missouri
-
Cape Girardeau, Missouri, Forenede Stater, 63703
- Rekruttering
- Saint Francis Medical Center
-
Ledende efterforsker:
- Bryan A. Faller
-
Kontakt:
- Site Public Contact
- Telefonnummer: 573-334-2230
- E-mail: sfmc@sfmc.net
-
-
Montana
-
Anaconda, Montana, Forenede Stater, 59711
- Rekruttering
- Community Hospital of Anaconda
-
Ledende efterforsker:
- John M. Schallenkamp
-
Kontakt:
- Site Public Contact
- Telefonnummer: 406-969-6060
- E-mail: mccinfo@mtcancer.org
-
Billings, Montana, Forenede Stater, 59101
- Rekruttering
- Billings Clinic Cancer Center
-
Ledende efterforsker:
- John M. Schallenkamp
-
Kontakt:
- Site Public Contact
- Telefonnummer: 800-996-2663
- E-mail: research@billingsclinic.org
-
Bozeman, Montana, Forenede Stater, 59715
- Rekruttering
- Bozeman Health Deaconess Hospital
-
Ledende efterforsker:
- John M. Schallenkamp
-
Kontakt:
- Site Public Contact
- Telefonnummer: 406-969-6060
- E-mail: mccinfo@mtcancer.org
-
Great Falls, Montana, Forenede Stater, 59405
- Rekruttering
- Benefis Sletten Cancer Institute
-
Ledende efterforsker:
- John M. Schallenkamp
-
Kontakt:
- Site Public Contact
- Telefonnummer: 406-969-6060
- E-mail: mccinfo@mtcancer.org
-
Kalispell, Montana, Forenede Stater, 59901
- Rekruttering
- Logan Health Medical Center
-
Ledende efterforsker:
- John M. Schallenkamp
-
Kontakt:
- Site Public Contact
- Telefonnummer: 406-969-6060
- E-mail: mccinfo@mtcancer.org
-
Missoula, Montana, Forenede Stater, 59804
- Rekruttering
- Community Medical Center
-
Ledende efterforsker:
- John M. Schallenkamp
-
Kontakt:
- Site Public Contact
- Telefonnummer: 406-969-6060
- E-mail: mccinfo@mtcancer.org
-
-
Nevada
-
Las Vegas, Nevada, Forenede Stater, 89102
- Suspenderet
- OptumCare Cancer Care at Charleston
-
Las Vegas, Nevada, Forenede Stater, 89183
- Suspenderet
- OptumCare Cancer Care at Fort Apache
-
-
New Jersey
-
Jersey City, New Jersey, Forenede Stater, 07302
- Rekruttering
- Jersey City Medical Center
-
Kontakt:
- Site Public Contact
- Telefonnummer: 412-339-5294
- E-mail: Roster@nrgoncology.org
-
Ledende efterforsker:
- Eugenia Girda
-
Lakewood, New Jersey, Forenede Stater, 08701
- Rekruttering
- Monmouth Medical Center Southern Campus
-
Kontakt:
- Site Public Contact
- Telefonnummer: 732-923-6564
- E-mail: mary.danish@rwjbh.org
-
Ledende efterforsker:
- Eugenia Girda
-
Long Branch, New Jersey, Forenede Stater, 07740
- Rekruttering
- Monmouth Medical Center
-
Kontakt:
- Site Public Contact
- Telefonnummer: 732-923-6564
- E-mail: mary.danish@rwjbh.org
-
Ledende efterforsker:
- Eugenia Girda
-
New Brunswick, New Jersey, Forenede Stater, 08903
- Rekruttering
- Rutgers Cancer Institute of New Jersey
-
Kontakt:
- Site Public Contact
- Telefonnummer: 732-235-7356
-
Ledende efterforsker:
- Eugenia Girda
-
Toms River, New Jersey, Forenede Stater, 08755
- Rekruttering
- Community Medical Center
-
Kontakt:
- Site Public Contact
- Telefonnummer: 732-557-8294
- E-mail: Lennette.Gonzales@rwjbh.org
-
Ledende efterforsker:
- Eugenia Girda
-
-
New Mexico
-
Albuquerque, New Mexico, Forenede Stater, 87106
- Rekruttering
- University of New Mexico Cancer Center
-
Kontakt:
- Site Public Contact
- Telefonnummer: 505-925-0348
- E-mail: HSC-ClinicalTrialInfo@salud.unm.edu
-
Ledende efterforsker:
- Carolyn Y. Muller
-
-
New York
-
Buffalo, New York, Forenede Stater, 14263
- Rekruttering
- Roswell Park Cancer Institute
-
Kontakt:
- Site Public Contact
- Telefonnummer: 800-767-9355
- E-mail: askroswell@roswellpark.org
-
Ledende efterforsker:
- Ellis G. Levine
-
Syracuse, New York, Forenede Stater, 13210
- Rekruttering
- State University of New York Upstate Medical University
-
Kontakt:
- Site Public Contact
- Telefonnummer: 315-464-5476
-
Ledende efterforsker:
- Mary J. Cunningham
-
Williamsville, New York, Forenede Stater, 14221
- Rekruttering
- Roswell Park Amherst Center
-
Kontakt:
- Site Public Contact
- Telefonnummer: 800-767-9355
- E-mail: askroswell@roswellpark.org
-
Ledende efterforsker:
- Ellis G. Levine
-
-
North Carolina
-
Asheboro, North Carolina, Forenede Stater, 27205
- Rekruttering
- Cone Health MedCenter Asheboro
-
Kontakt:
- Site Public Contact
- Telefonnummer: 336-832-0836
- E-mail: stacey.phelps@conehealth.com
-
Ledende efterforsker:
- Ni Gorsuch
-
Burlington, North Carolina, Forenede Stater, 27215
- Rekruttering
- Cone Health Cancer Center at Alamance Regional
-
Kontakt:
- Site Public Contact
- Telefonnummer: 336-832-0836
- E-mail: stacey.phelps@conehealth.com
-
Ledende efterforsker:
- Ni Gorsuch
-
Clinton, North Carolina, Forenede Stater, 28328
- Rekruttering
- Southeastern Medical Oncology Center-Clinton
-
Kontakt:
- Site Public Contact
- Telefonnummer: 919-587-9084
- E-mail: jfields@cancersmoc.com
-
Ledende efterforsker:
- Samer S. Kasbari
-
Durham, North Carolina, Forenede Stater, 27710
- Rekruttering
- Duke University Medical Center
-
Ledende efterforsker:
- Angeles A. Secord
-
Kontakt:
- Site Public Contact
- Telefonnummer: 888-275-3853
-
Goldsboro, North Carolina, Forenede Stater, 27534
- Rekruttering
- Southeastern Medical Oncology Center-Goldsboro
-
Kontakt:
- Site Public Contact
- Telefonnummer: 919-587-9084
- E-mail: jfields@cancersmoc.com
-
Ledende efterforsker:
- Samer S. Kasbari
-
Greensboro, North Carolina, Forenede Stater, 27403
- Rekruttering
- Cone Health Cancer Center
-
Kontakt:
- Site Public Contact
- Telefonnummer: 336-832-0836
- E-mail: stacey.phelps@conehealth.com
-
Ledende efterforsker:
- Ni Gorsuch
-
Greensboro, North Carolina, Forenede Stater, 27410
- Rekruttering
- Cone Health Cancer Center at Drawbridge Parkway
-
Kontakt:
- Site Public Contact
- Telefonnummer: 336-832-0836
- E-mail: stacey.phelps@conehealth.com
-
Ledende efterforsker:
- Ni Gorsuch
-
Jacksonville, North Carolina, Forenede Stater, 28546
- Rekruttering
- Southeastern Medical Oncology Center-Jacksonville
-
Ledende efterforsker:
- Samer S. Kasbari
-
Kontakt:
- Site Public Contact
- Telefonnummer: 910-587-9084
- E-mail: jfields@cancersmoc.com
-
Raleigh, North Carolina, Forenede Stater, 27607
- Rekruttering
- Duke Women's Cancer Care Raleigh
-
Ledende efterforsker:
- Angeles A. Secord
-
Kontakt:
- Site Public Contact
- Telefonnummer: 919-785-4878
-
Reidsville, North Carolina, Forenede Stater, 27320
- Rekruttering
- Annie Penn Memorial Hospital
-
Kontakt:
- Site Public Contact
- Telefonnummer: 336-832-0836
- E-mail: stacey.phelps@conehealth.com
-
Ledende efterforsker:
- Ni Gorsuch
-
-
North Dakota
-
Bismarck, North Dakota, Forenede Stater, 58501
- Rekruttering
- Sanford Bismarck Medical Center
-
Ledende efterforsker:
- Daniel Almquist
-
Kontakt:
- Site Public Contact
- Telefonnummer: 701-323-5760
- E-mail: OncologyClinicalTrialsFargo@sanfordhealth.org
-
Fargo, North Dakota, Forenede Stater, 58122
- Rekruttering
- Sanford Broadway Medical Center
-
Ledende efterforsker:
- Daniel Almquist
-
Kontakt:
- Site Public Contact
- Telefonnummer: 701-323-5760
- E-mail: OncologyClinicalTrialsFargo@sanfordhealth.org
-
Fargo, North Dakota, Forenede Stater, 58122
- Rekruttering
- Sanford Roger Maris Cancer Center
-
Ledende efterforsker:
- Daniel Almquist
-
Kontakt:
- Site Public Contact
- Telefonnummer: 701-234-6161
- E-mail: OncologyClinicalTrialsFargo@sanfordhealth.org
-
-
Ohio
-
Athens, Ohio, Forenede Stater, 45701
- Rekruttering
- OhioHealth O'Bleness Hospital
-
Ledende efterforsker:
- Aine E. Clements
-
Kontakt:
- Site Public Contact
- Telefonnummer: 614-788-3860
- E-mail: Jennifer.Sexton@ohiohealth.com
-
Centerville, Ohio, Forenede Stater, 45459
- Rekruttering
- Miami Valley Hospital South
-
Kontakt:
- Site Public Contact
- Telefonnummer: 937-528-2900
- E-mail: clinical.trials@daytonncorp.org
-
Ledende efterforsker:
- Tarek M. Sabagh
-
Columbus, Ohio, Forenede Stater, 43214
- Rekruttering
- Columbus Oncology and Hematology Associates Inc
-
Ledende efterforsker:
- Aine E. Clements
-
Kontakt:
- Site Public Contact
- Telefonnummer: 614-788-3860
- E-mail: Jennifer.Sexton@ohiohealth.com
-
Columbus, Ohio, Forenede Stater, 43214
- Rekruttering
- Riverside Methodist Hospital
-
Ledende efterforsker:
- Aine E. Clements
-
Kontakt:
- Site Public Contact
- Telefonnummer: 614-788-3860
- E-mail: Jennifer.Sexton@ohiohealth.com
-
Columbus, Ohio, Forenede Stater, 43215
- Rekruttering
- Grant Medical Center
-
Ledende efterforsker:
- Aine E. Clements
-
Kontakt:
- Site Public Contact
- Telefonnummer: 614-788-3860
- E-mail: Jennifer.Sexton@ohiohealth.com
-
Columbus, Ohio, Forenede Stater, 43228
- Rekruttering
- Doctors Hospital
-
Ledende efterforsker:
- Aine E. Clements
-
Kontakt:
- Site Public Contact
- Telefonnummer: 614-788-3860
- E-mail: Jennifer.Sexton@ohiohealth.com
-
Columbus, Ohio, Forenede Stater, 43210
- Rekruttering
- Ohio State University Comprehensive Cancer Center
-
Kontakt:
- Site Public Contact
- Telefonnummer: 800-293-5066
- E-mail: Jamesline@osumc.edu
-
Ledende efterforsker:
- Floor Backes
-
Dayton, Ohio, Forenede Stater, 45409
- Rekruttering
- Miami Valley Hospital
-
Kontakt:
- Site Public Contact
- Telefonnummer: 937-528-2900
- E-mail: clinical.trials@daytonncorp.org
-
Ledende efterforsker:
- Tarek M. Sabagh
-
Dayton, Ohio, Forenede Stater, 45415
- Rekruttering
- Miami Valley Hospital North
-
Kontakt:
- Site Public Contact
- Telefonnummer: 937-528-2900
- E-mail: clinical.trials@daytonncorp.org
-
Ledende efterforsker:
- Tarek M. Sabagh
-
Dayton, Ohio, Forenede Stater, 45409
- Rekruttering
- Premier Blood and Cancer Center
-
Kontakt:
- Site Public Contact
- Telefonnummer: 937-276-8320
-
Ledende efterforsker:
- Tarek M. Sabagh
-
Dayton, Ohio, Forenede Stater, 45415
- Suspenderet
- Dayton Physician LLC - Englewood
-
Delaware, Ohio, Forenede Stater, 43015
- Rekruttering
- Delaware Health Center-Grady Cancer Center
-
Ledende efterforsker:
- Aine E. Clements
-
Kontakt:
- Site Public Contact
- Telefonnummer: 614-788-3860
- E-mail: Jennifer.Sexton@ohiohealth.com
-
Delaware, Ohio, Forenede Stater, 43015
- Rekruttering
- Grady Memorial Hospital
-
Ledende efterforsker:
- Aine E. Clements
-
Kontakt:
- Site Public Contact
- Telefonnummer: 614-788-3860
- E-mail: Jennifer.Sexton@ohiohealth.com
-
Dublin, Ohio, Forenede Stater, 43016
- Rekruttering
- Columbus Oncology and Hematology Associates
-
Ledende efterforsker:
- Aine E. Clements
-
Kontakt:
- Site Public Contact
- Telefonnummer: 614-788-3860
- E-mail: Jennifer.Sexton@ohiohealth.com
-
Dublin, Ohio, Forenede Stater, 43016
- Rekruttering
- Dublin Methodist Hospital
-
Ledende efterforsker:
- Aine E. Clements
-
Kontakt:
- Site Public Contact
- Telefonnummer: 614-788-3860
- E-mail: Jennifer.Sexton@ohiohealth.com
-
Franklin, Ohio, Forenede Stater, 45005-1066
- Rekruttering
- Atrium Medical Center-Middletown Regional Hospital
-
Kontakt:
- Site Public Contact
- Telefonnummer: 937-528-2900
- E-mail: clinical.trials@daytonncorp.org
-
Ledende efterforsker:
- Tarek M. Sabagh
-
Greenville, Ohio, Forenede Stater, 45331
- Rekruttering
- Miami Valley Cancer Care and Infusion
-
Ledende efterforsker:
- Tarek M. Sabagh
-
Kontakt:
- Site Public Contact
- Telefonnummer: 937-569-7515
-
Kettering, Ohio, Forenede Stater, 45429
- Suspenderet
- Kettering Medical Center
-
Mansfield, Ohio, Forenede Stater, 44903
- Rekruttering
- OhioHealth Mansfield Hospital
-
Ledende efterforsker:
- Aine E. Clements
-
Kontakt:
- Site Public Contact
- Telefonnummer: 614-788-3860
- E-mail: Jennifer.Sexton@ohiohealth.com
-
Marion, Ohio, Forenede Stater, 43302
- Rekruttering
- OhioHealth Marion General Hospital
-
Ledende efterforsker:
- Aine E. Clements
-
Kontakt:
- Site Public Contact
- Telefonnummer: 614-788-3860
- E-mail: Jennifer.Sexton@ohiohealth.com
-
Pickerington, Ohio, Forenede Stater, 43147
- Rekruttering
- OhioHealth Pickerington Methodist Hospital
-
Ledende efterforsker:
- Aine E. Clements
-
Kontakt:
- Site Public Contact
- Telefonnummer: 614-788-3860
- E-mail: Jennifer.Sexton@ohiohealth.com
-
Troy, Ohio, Forenede Stater, 45373
- Rekruttering
- Upper Valley Medical Center
-
Kontakt:
- Site Public Contact
- Telefonnummer: 937-528-2900
- E-mail: clinical.trials@daytonncorp.org
-
Ledende efterforsker:
- Tarek M. Sabagh
-
Westerville, Ohio, Forenede Stater, 43082
- Rekruttering
- OhioHealth Westerville Medical Campus/Westerville Cancer Center
-
Ledende efterforsker:
- Aine E. Clements
-
Kontakt:
- Site Public Contact
- Telefonnummer: 610-788-3860
- E-mail: Jennifer.Sexton@ohiohealth.com
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Forenede Stater, 73104
- Rekruttering
- University of Oklahoma Health Sciences Center
-
Kontakt:
- Site Public Contact
- Telefonnummer: 405-271-8777
- E-mail: ou-clinical-trials@ouhsc.edu
-
Ledende efterforsker:
- Lauren E. Dockery
-
-
Oregon
-
Ontario, Oregon, Forenede Stater, 97914
- Rekruttering
- Saint Alphonsus Cancer Care Center-Ontario
-
Kontakt:
- Site Public Contact
- Telefonnummer: 406-969-6060
- E-mail: mccinfo@mtcancer.org
-
Ledende efterforsker:
- Tareq Al baghdadi
-
Portland, Oregon, Forenede Stater, 97239
- Rekruttering
- Oregon Health and Science University
-
Ledende efterforsker:
- Elizabeth G. Munro
-
Kontakt:
- Site Public Contact
- Telefonnummer: 503-494-1080
- E-mail: trials@ohsu.edu
-
Portland, Oregon, Forenede Stater, 97213
- Rekruttering
- Providence Portland Medical Center
-
Ledende efterforsker:
- Dan S. Zuckerman
-
Kontakt:
- Site Public Contact
- Telefonnummer: 503-215-2614
- E-mail: CanRsrchStudies@providence.org
-
Portland, Oregon, Forenede Stater, 97225
- Rekruttering
- Providence Saint Vincent Medical Center
-
Ledende efterforsker:
- Dan S. Zuckerman
-
Kontakt:
- Site Public Contact
- Telefonnummer: 503-215-2614
- E-mail: CanRsrchStudies@providence.org
-
-
Pennsylvania
-
Altoona, Pennsylvania, Forenede Stater, 16601
- Rekruttering
- UPMC Altoona
-
Kontakt:
- Site Public Contact
- Telefonnummer: 412-339-5294
- E-mail: Roster@nrgoncology.org
-
Ledende efterforsker:
- Sarah E. Taylor
-
Erie, Pennsylvania, Forenede Stater, 16505
- Rekruttering
- UPMC Hillman Cancer Center Erie
-
Ledende efterforsker:
- Sarah E. Taylor
-
Kontakt:
- Site Public Contact
- Telefonnummer: 412-864-7716
- E-mail: ClinicalResearchServices@upmc.edu
-
Greensburg, Pennsylvania, Forenede Stater, 15601
- Rekruttering
- UPMC Cancer Centers - Arnold Palmer Pavilion
-
Kontakt:
- Site Public Contact
- Telefonnummer: 724-838-1900
-
Ledende efterforsker:
- Sarah E. Taylor
-
Mechanicsburg, Pennsylvania, Forenede Stater, 17050
- Rekruttering
- UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion
-
Kontakt:
- Site Public Contact
- Telefonnummer: 412-389-5208
- E-mail: haneydl@upmc.edu
-
Ledende efterforsker:
- Sarah E. Taylor
-
Monroeville, Pennsylvania, Forenede Stater, 15146
- Rekruttering
- UPMC Hillman Cancer Center - Monroeville
-
Ledende efterforsker:
- Sarah E. Taylor
-
Kontakt:
- Site Public Contact
- Telefonnummer: 412-864-7716
- E-mail: ClinicalResearchServices@upmc.edu
-
Philadelphia, Pennsylvania, Forenede Stater, 19107
- Rekruttering
- Thomas Jefferson University Hospital
-
Kontakt:
- Site Public Contact
- Telefonnummer: 215-600-9151
- E-mail: ONCTrialNow@jefferson.edu
-
Ledende efterforsker:
- Mitchell I. Edelson
-
Pittsburgh, Pennsylvania, Forenede Stater, 15213
- Rekruttering
- UPMC-Magee Womens Hospital
-
Kontakt:
- Site Public Contact
- Telefonnummer: 412-647-2811
-
Ledende efterforsker:
- Sarah E. Taylor
-
Pittsburgh, Pennsylvania, Forenede Stater, 15237
- Rekruttering
- UPMC-Passavant Hospital
-
Kontakt:
- Site Public Contact
- Telefonnummer: 412-367-6454
-
Ledende efterforsker:
- Sarah E. Taylor
-
Pittsburgh, Pennsylvania, Forenede Stater, 15232
- Rekruttering
- UPMC Hillman Cancer Center
-
Kontakt:
- Site Public Contact
- Telefonnummer: 412-647-8073
-
Ledende efterforsker:
- Sarah E. Taylor
-
Willow Grove, Pennsylvania, Forenede Stater, 19090
- Rekruttering
- Asplundh Cancer Pavilion
-
Kontakt:
- Site Public Contact
- Telefonnummer: 215-600-9151
- E-mail: ONCTrialNow@jefferson.edu
-
Ledende efterforsker:
- Mitchell I. Edelson
-
-
Rhode Island
-
Providence, Rhode Island, Forenede Stater, 02905
- Rekruttering
- Women and Infants Hospital
-
Kontakt:
- Site Public Contact
- Telefonnummer: 401-274-1122
-
Ledende efterforsker:
- Paul A. DiSilvestro
-
-
South Dakota
-
Sioux Falls, South Dakota, Forenede Stater, 57104
- Rekruttering
- Sanford Cancer Center Oncology Clinic
-
Ledende efterforsker:
- Daniel Almquist
-
Kontakt:
- Site Public Contact
- Telefonnummer: 605-312-3320
- E-mail: OncologyClinicTrialsSF@sanfordhealth.org
-
Sioux Falls, South Dakota, Forenede Stater, 57117-5134
- Rekruttering
- Sanford USD Medical Center - Sioux Falls
-
Ledende efterforsker:
- Daniel Almquist
-
Kontakt:
- Site Public Contact
- Telefonnummer: 605-312-3320
- E-mail: OncologyClinicalTrialsSF@SanfordHealth.org
-
-
Tennessee
-
Bristol, Tennessee, Forenede Stater, 37620
- Rekruttering
- Bristol Regional Medical Center
-
Ledende efterforsker:
- Asheesh Shipstone
-
Kontakt:
- Site Public Contact
- Telefonnummer: 423-431-5654
- E-mail: charles.mays@balladhealth.org
-
Johnson City, Tennessee, Forenede Stater, 37604
- Rekruttering
- Regional Cancer Center at Johnson City Medical Center
-
Ledende efterforsker:
- Asheesh Shipstone
-
Kontakt:
- Site Public Contact
- Telefonnummer: 423-431-5654
- E-mail: charles.mays@balladhealth.org
-
Kingsport, Tennessee, Forenede Stater, 37660
- Rekruttering
- Ballad Health Cancer Care - Kingsport
-
Ledende efterforsker:
- Asheesh Shipstone
-
Kontakt:
- Site Public Contact
- Telefonnummer: 423-431-5654
- E-mail: charles.mays@balladhealth.org
-
Kingsport, Tennessee, Forenede Stater, 37660
- Rekruttering
- Wellmont Holston Valley Hospital and Medical Center
-
Ledende efterforsker:
- Asheesh Shipstone
-
Kontakt:
- Site Public Contact
- Telefonnummer: 423-431-5654
- E-mail: charles.mays@balladhealth.org
-
Nashville, Tennessee, Forenede Stater, 37232
- Rekruttering
- Vanderbilt University/Ingram Cancer Center
-
Kontakt:
- Site Public Contact
- Telefonnummer: 800-811-8480
-
Ledende efterforsker:
- Jennifer H. Choe
-
-
Texas
-
Dallas, Texas, Forenede Stater, 75390
- Rekruttering
- UT Southwestern/Simmons Cancer Center-Dallas
-
Kontakt:
- Site Public Contact
- Telefonnummer: 214-648-7097
- E-mail: canceranswerline@UTSouthwestern.edu
-
Ledende efterforsker:
- James L. Wilder
-
Dallas, Texas, Forenede Stater, 75235
- Rekruttering
- Parkland Memorial Hospital
-
Kontakt:
- Site Public Contact
- Telefonnummer: 214-590-5582
- E-mail: canceranswerline@UTSouthwestern.edu
-
Ledende efterforsker:
- James L. Wilder
-
Fort Worth, Texas, Forenede Stater, 76104
- Rekruttering
- UT Southwestern/Simmons Cancer Center-Fort Worth
-
Kontakt:
- Site Public Contact
- Telefonnummer: 214-648-7097
- E-mail: canceranswerline@UTSouthwestern.edu
-
Ledende efterforsker:
- James L. Wilder
-
Houston, Texas, Forenede Stater, 77030
- Rekruttering
- UT MD Anderson Cancer Center
-
Kontakt:
- Site Public Contact
- Telefonnummer: 866-632-6789
- E-mail: askmdanderson@mdanderson.org
-
Ledende efterforsker:
- Sarina A. Piha-Paul
-
Richardson, Texas, Forenede Stater, 75080
- Rekruttering
- UT Southwestern Clinical Center at Richardson/Plano
-
Kontakt:
- Site Public Contact
- Telefonnummer: 972-669-7044
- E-mail: Suzanne.cole@utsouthwestern.edu
-
Ledende efterforsker:
- James L. Wilder
-
Temple, Texas, Forenede Stater, 76508
- Rekruttering
- Scott and White Memorial Hospital
-
Kontakt:
- Site Public Contact
- Telefonnummer: 254-724-5407
-
Ledende efterforsker:
- Lucas Wong
-
-
Virginia
-
Bristol, Virginia, Forenede Stater, 24201
- Rekruttering
- Ballad Health Cancer Care - Bristol
-
Ledende efterforsker:
- Asheesh Shipstone
-
Kontakt:
- Site Public Contact
- Telefonnummer: 423-431-5654
- E-mail: charles.mays@balladhealth.org
-
Charlottesville, Virginia, Forenede Stater, 22908
- Rekruttering
- University of Virginia Cancer Center
-
Ledende efterforsker:
- Matthew J. Reilley
-
Kontakt:
- Site Public Contact
- Telefonnummer: 434-243-6303
- E-mail: uvacancertrials@hscmail.mcc.virginia.edu
-
Fairfax, Virginia, Forenede Stater, 22031
- Rekruttering
- Inova Schar Cancer Institute
-
Ledende efterforsker:
- Timothy L. Cannon
-
Kontakt:
- Site Public Contact
- Telefonnummer: 703-720-5210
- E-mail: Stephanie.VanBebber@inova.org
-
Falls Church, Virginia, Forenede Stater, 22042
- Rekruttering
- Inova Fairfax Hospital
-
Ledende efterforsker:
- Timothy L. Cannon
-
Kontakt:
- Site Public Contact
- Telefonnummer: 703-208-6650
- E-mail: Stephanie.VanBebber@inova.org
-
Richmond, Virginia, Forenede Stater, 23298
- Aktiv, ikke rekrutterende
- VCU Massey Comprehensive Cancer Center
-
Roanoke, Virginia, Forenede Stater, 24033
- Aktiv, ikke rekrutterende
- Carilion Roanoke Memorial Hospital
-
-
Washington
-
Edmonds, Washington, Forenede Stater, 98026
- Rekruttering
- Swedish Cancer Institute-Edmonds
-
Ledende efterforsker:
- Dan S. Zuckerman
-
Kontakt:
- Site Public Contact
- Telefonnummer: 206-215-2343
- E-mail: PCRC-NCORP@Swedish.org
-
Issaquah, Washington, Forenede Stater, 98029
- Rekruttering
- Swedish Cancer Institute-Issaquah
-
Ledende efterforsker:
- Dan S. Zuckerman
-
Kontakt:
- Site Public Contact
- Telefonnummer: 206-215-2343
- E-mail: PCRC-NCORP@Swedish.org
-
Seattle, Washington, Forenede Stater, 98122
- Rekruttering
- Swedish Medical Center-First Hill
-
Ledende efterforsker:
- Dan S. Zuckerman
-
Kontakt:
- Site Public Contact
- Telefonnummer: 206-215-2343
- E-mail: PCRC-NCORP@Swedish.org
-
-
West Virginia
-
Morgantown, West Virginia, Forenede Stater, 26506
- Rekruttering
- West Virginia University Healthcare
-
Kontakt:
- Site Public Contact
- Telefonnummer: 304-293-7374
- E-mail: cancertrialsinfo@hsc.wvu.edu
-
Ledende efterforsker:
- Mohammed Almubarak
-
-
Wisconsin
-
Ashland, Wisconsin, Forenede Stater, 54806
- Rekruttering
- Duluth Clinic Ashland
-
Kontakt:
- Site Public Contact
- Telefonnummer: 218-786-3308
- E-mail: CancerTrials@EssentiaHealth.org
-
Ledende efterforsker:
- Bret E. Friday
-
Eau Claire, Wisconsin, Forenede Stater, 54701
- Rekruttering
- Marshfield Medical Center-EC Cancer Center
-
Kontakt:
- Site Public Contact
- Telefonnummer: 800-782-8581
- E-mail: oncology.clinical.trials@marshfieldresearch.org
-
Ledende efterforsker:
- Adedayo A. Onitilo
-
Green Bay, Wisconsin, Forenede Stater, 54301
- Rekruttering
- Saint Vincent Hospital Cancer Center Green Bay
-
Ledende efterforsker:
- Matthew L. Ryan
-
Kontakt:
- Site Public Contact
- Telefonnummer: 920-433-8889
- E-mail: WI_research_admin@hshs.org
-
Green Bay, Wisconsin, Forenede Stater, 54303
- Rekruttering
- Saint Vincent Hospital Cancer Center at Saint Mary's
-
Ledende efterforsker:
- Matthew L. Ryan
-
Kontakt:
- Site Public Contact
- Telefonnummer: 920-433-8889
- E-mail: wi_research_admin@hshs.org
-
La Crosse, Wisconsin, Forenede Stater, 54601
- Rekruttering
- Gundersen Lutheran Medical Center
-
Kontakt:
- Site Public Contact
- Telefonnummer: 608-775-2385
- E-mail: cancerctr@gundersenhealth.org
-
Ledende efterforsker:
- Collin D. Driscoll
-
Marshfield, Wisconsin, Forenede Stater, 54449
- Rekruttering
- Marshfield Medical Center-Marshfield
-
Kontakt:
- Site Public Contact
- Telefonnummer: 800-782-8581
- E-mail: oncology.clinical.trials@marshfieldresearch.org
-
Ledende efterforsker:
- Adedayo A. Onitilo
-
Minocqua, Wisconsin, Forenede Stater, 54548
- Rekruttering
- Marshfield Medical Center - Minocqua
-
Kontakt:
- Site Public Contact
- Telefonnummer: 800-782-8581
- E-mail: oncology.clinical.trials@marshfieldresearch.org
-
Ledende efterforsker:
- Adedayo A. Onitilo
-
New Richmond, Wisconsin, Forenede Stater, 54017
- Rekruttering
- Cancer Center of Western Wisconsin
-
Ledende efterforsker:
- Joleen M. Hubbard
-
Kontakt:
- Site Public Contact
- Telefonnummer: 952-993-1517
- E-mail: mmcorc@healthpartners.com
-
Oconto Falls, Wisconsin, Forenede Stater, 54154
- Rekruttering
- Saint Vincent Hospital Cancer Center at Oconto Falls
-
Ledende efterforsker:
- Matthew L. Ryan
-
Kontakt:
- Site Public Contact
- Telefonnummer: 920-433-8889
- E-mail: WI_research_admin@hshs.org
-
Rice Lake, Wisconsin, Forenede Stater, 54868
- Rekruttering
- Marshfield Medical Center-Rice Lake
-
Kontakt:
- Site Public Contact
- Telefonnummer: 800-782-8581
- E-mail: oncology.clinical.trials@marshfieldresearch.org
-
Ledende efterforsker:
- Adedayo A. Onitilo
-
Sheboygan, Wisconsin, Forenede Stater, 53081
- Rekruttering
- Saint Vincent Hospital Cancer Center at Sheboygan
-
Ledende efterforsker:
- Matthew L. Ryan
-
Kontakt:
- Site Public Contact
- Telefonnummer: 920-433-8889
- E-mail: wi_research_admin@hshs.org
-
Stevens Point, Wisconsin, Forenede Stater, 54482
- Rekruttering
- Marshfield Medical Center-River Region at Stevens Point
-
Kontakt:
- Site Public Contact
- Telefonnummer: 800-782-8581
- E-mail: oncology.clinical.trials@marshfieldresearch.org
-
Ledende efterforsker:
- Adedayo A. Onitilo
-
Sturgeon Bay, Wisconsin, Forenede Stater, 54235-1495
- Rekruttering
- Saint Vincent Hospital Cancer Center at Sturgeon Bay
-
Ledende efterforsker:
- Matthew L. Ryan
-
Kontakt:
- Site Public Contact
- Telefonnummer: 920-433-8889
- E-mail: wi_research_admin@hshs.org
-
Weston, Wisconsin, Forenede Stater, 54476
- Rekruttering
- Marshfield Medical Center - Weston
-
Kontakt:
- Site Public Contact
- Telefonnummer: 800-782-8581
- E-mail: oncology.clinical.trials@marshfieldresearch.org
-
Ledende efterforsker:
- Adedayo A. Onitilo
-
-
-
-
-
San Juan, Puerto Rico, 00927
- Rekruttering
- Centro Comprensivo de Cancer de UPR
-
Ledende efterforsker:
- Luis J. Santos Reyes
-
Kontakt:
- Site Public Contact
- Telefonnummer: 412-339-5294
- E-mail: Roster@nrgoncology.org
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
-
Patient must have enrolled onto EAY191 and must have been given a treatment assignment to ComboMATCH to EAY191-N5 based on the presence of an actionable mutation as defined in EAY191
-
Patients must have a HER2 amplified solid tumor except breast cancer.
-
If IHC is 0 or 1+, patient (pt) is NOT ELIGIBLE regardless of in situ hybridization (ISH)/FISH or next generation sequencing (NGS) status
-
If IHC is 3+, pt IS ELIGIBLE regardless of ISH/FISH or NGS status
-
If IHC is 2+, ISH/FISH OR NGS must be positive for the patient to be ELIGIBLE. Otherwise, pt is NOT ELIGIBLE
-
If IHC is unknown and…
- ISH/FISH is positive, independent of NGS results, the patient IS ELIGIBLE
- ISH/FISH is negative and NGS positive with ≥ 7 copies, the patient IS ELIGIBLE
-
-
Patients must have recurrent or persistent disease
-
No known evidence of RB1 loss or deletion including copy number loss or deleterious mutation
-
Patients must have disease that can be safely biopsied and agree to a pre-treatment biopsy or, if disease cannot be safely biopsied, have archival tissue available from within 12 months prior to the date of registration on the ComboMATCH Registration Trial (EAY191)
-
Patients must have measurable disease based on RECIST 1.1. A second measurable lesion outside of the biopsiable lesion is required
-
Patients with treated brain metastases are eligible if follow up brain imaging after central nervous system (CNS) directed therapy shows no evidence of progression for 3 months or more and patient is not on steroids and is asymptomatic
-
No known leptomeningeal disease
-
Patients may have received up to 5 prior lines of systemic therapy
-
Prior therapy with trastuzumab or pertuzumab, either alone or in combination, antibody drug conjugates (ADC) such as DS8201a or T-DM1 is allowed
-
No prior therapy with HER2 targeting tyrosine kinase inhibitors (TKI) such as neratinib or tucatinib
-
No prior therapy with CDK4/6 inhibition
-
No cancer directed therapy within 3 weeks prior to registration. For oral therapy, the washout can be reduced to greater than or equal to 5 half lives of the drug. No HER2 targeting ADCs within 30 days prior to registration
-
Age ≥ 18
-
Eastern Cooperative Oncology Group (ECOG) Performance Status of ≤ 2
-
Not pregnant and not nursing
-
Absolute neutrophil count (ANC) ≥ 1,500 cells/mm^3
-
Platelets ≥ 100,000 cells/mm^3
-
Hemoglobin ≥ 9 g/dl (Note: The use of transfusion or other intervention to achieve hemoglobin (Hgb) ≥ 9 g/dl is acceptable)
-
Creatinine clearance (CrCL) of ≥ 30 mL/min by the Cockcroft-Gault formula
-
Total bilirubin level ≤ 1.5 x institutional upper limit of normal (ULN) (patients with known Gilbert's disease who have bilirubin level ≤ 3 x institutional ULN may be enrolled)
-
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤ 3 x institutional upper limit of normal (ULN)
-
Patients with known history or current symptoms of cardiac disease, or history of treatment with cardiotoxic agents, should have a clinical risk assessment of cardiac function using the New York Heart Association Functional Classification. To be eligible for this trial, patients should be class 2B or better
-
No active infection requiring parenteral antibiotics
-
No current evidence of intra-abdominal abscess, abdominal/pelvic fistula (not diverted), gastrointestinal perforation, gastrointestinal (GI) obstruction, and/or need for drainage nasogastric or gastrostomy tube
-
No current evidence of malabsorption or chronic diarrhea or any other significant gastro-intestinal disease (e.g gastrectomy, ileal bypass, Crohn's disease, gastroparesis), associated with moderate to severe diarrhea (grade 2 or more) or inability to tolerate oral therapy
-
No lung disease causing dyspnea at rest
-
No interstitial lung disease with ongoing signs and symptoms at the time of registration
-
No history of allergic reaction to the study agents, compound of similar chemical or biologic composition of the study agents or any of their excipients
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Arm I (neratinib maleate)
Patients receive neratinib maleate PO QD on days 1-14 of cycle 0 in the absence of disease progression or unacceptable toxicity. Patients then receive neratinib maleate PO QD on days 1-28 of each subsequent cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients who experience progression may crossover to Arm II. Patients undergo ECHO or MUGA during screening and on study, and CT or MRI and collection of blood samples throughout the trial. Patients may also undergo tumor biopsy during screening and on study. |
Undergo MRI
Andre navne:
Undergo ECHO
Andre navne:
Undergo MUGA
Andre navne:
Undergo collection of blood samples
Andre navne:
Undergo CT scan
Andre navne:
Undergo tumor biopsy
Andre navne:
Given PO
Andre navne:
|
|
Eksperimentel: Arm II (neratinib maleate, palbociclib)
Patients receive neratinib maleate PO QD on days 1-14 of cycle 0 in the absence of disease progression or unacceptable toxicity. Patients then receive neratinib maleate PO QD on days 1-28 and palbociclib PO QD on days 1-21 of each subsequent cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients undergo ECHO or MUGA during screening and on study, and CT or MRI and collection of blood samples throughout the trial. Patients may also undergo tumor biopsy during screening and on study. |
Undergo MRI
Andre navne:
Undergo ECHO
Andre navne:
Undergo MUGA
Andre navne:
Undergo collection of blood samples
Andre navne:
Undergo CT scan
Andre navne:
Undergo tumor biopsy
Andre navne:
Given PO
Andre navne:
Given PO
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Progression free survival
Tidsramme: From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 2 years
|
The stratified log-rank statistic will be used to draw inferences about the relative activity of the two regimens. Characterized by medians and Kaplan-Meier (KM) curves. |
From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 2 years
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Overall survival
Tidsramme: Up to 2 years
|
The impact of treatment on the hazard of death can be investigated with time dependent covariates. |
Up to 2 years
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Haider S Mahdi, NRG Oncology
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Undersøgelsesteknikker
- Kliniske laboratorieteknikker
- Diagnostiske teknikker og procedurer
- Diagnose
- Kirurgiske procedurer, operative
- Cytologiske teknikker
- Cytodiagnose
- Diagnostiske teknikker, kirurgisk
- Kemiteknikker, analytisk
- Spektrumanalyse
- Biopsi
- Håndtering af eksemplar
- Magnetisk resonansspektroskopi
- Palbociclib
- neratinib
Andre undersøgelses-id-numre
- NCI-2023-09270
- U10CA180868 (U.S. NIH-bevilling/kontrakt)
- NCI-2023-09270 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
- EAY191-N5 (Anden identifikator: CTEP)
- EAY191-N5 (Anden identifikator: NRG Oncology)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .